banner
Metabolism inhibitor, Cytochrome P450 14a-demethylase inhibitor 1h, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM367

Metabolism inhibitor, Cytochrome P450 14a-demethylase inhibitor 1h, Purity ≥98%

Synonym: 1155361-06-0; 1-[(2-Bromophenyl)methyl-prop-2-enylamino]-2-(2,4-difluorophenyl)-3-(1,2,4-triazol-1-yl)propan-2-ol

  • CAS Number: 1155361-06-0
  • Compound CID: 42631372
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Cytochrome P450 14a-demethylase inhibitor 1h is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Weight
463.3
Molecular Formula
C21H21ClF2N4O
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Cytochrome P450 14a-demethylase inhibitor 1h is a metabolism inhibitor that plays a key role in drug discovery efforts to identify and optimize compounds that selectively inhibit fungal CYP51 without affecting human CYP51.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0